References
- Gücer F, Tamussino K, Keil F, Balkanli-Kaplan P, Yüce MA. Thrombocytosis in gynecologic malignancies. Anticancer Res 2004;24:2053–9.
- D'Hondt V, Humblet Y, Guillaume T, Baatout S, Chatelain C, Berliere M, Thrombopoetic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicenter placebo-controlled randomised phase Ib study. Blood 1995;85:2347–53.
- Pedersen LM, Milman N. Diagnostic significance of platelet count and other blood analyses in patients with lung cancer. Oncol Rep 2003;10:213–16.
- Chalas E, Welshinger M, Engellener W, Chumas J, Barbieri R, Mann WJ. The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 1992;166:974–7.
- Diehl WL, Mandelbaum I. The significance of thrombocytosis in patients with carcinoma of the lung. Surg Gynecol Obstet 1983;156:187–188.
- Masataka I, Hiroshi F, Hiroshi I, Jyunzo S, Hideyuki I, Seizo M, Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287–91.